An Inversion Affecting the GCH1 Gene as a Novel Finding in Dopa-Responsive Dystonia

Affiliations

• ¹ Neurology Department, Concord Repatriation General Hospital, Sydney, New South Wales, Australia.
• ² Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
• ³ Garvan Institute of Medical Research, Sydney, New South Wales, Australia.
• ⁴ The Neurogenetics Clinic, Raphael Recanati Genetics Institute, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.
• ⁵ Molecular Medicine Laboratory, Concord Repatriation General Hospital, Sydney, New South Wales, Australia.
• ⁶ Northcott Neuroscience Laboratory, ANZAC Research Institute-Sydney Local Health District, Concord, New South Wales, Australia.
• ⁷ Clinical Genetics Service, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
• ⁸ Department of Medical Genomics, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
• ⁹ Concord Clinical School, Sydney Medical School, Faculty of Health and Medicine, University of Sydney, Sydney, New South Wales, Australia.
• ¹⁰ Royal Prince Alfred Hospital, New South Wales Health Pathology, Sydney, New South Wales, Australia.
• ¹¹ Institute of Precision Medicine and Bioinformatics, Sydney Local Health District, Sydney, New South Wales, Australia.
• ¹² Neuroscience Research Australia, Sydney, New South Wales, Australia.
• ¹³ Ancestry and Health Genomics Laboratory, Charles Perkins Centre, School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
• ¹⁴ School of Health Systems & Public Health, University of Pretoria, Pretoria, South Africa.
• ¹⁵ Manchester Cancer Research Centre, University of Manchester, Manchester, UK.